Search
Sign In
Sign In
Sources
12 Total Sources
Analysts Doubt $130 Billion AstraZeneca-BMS Merger as Antitrust Overlap Clouds Historic Pharma Deal
Left
33%
Center
33%
Right
33%
All
12
Left
1
Center
1
Right
1
Others
9
BioSpace
20d ago
Analysts Skeptical of AstraZeneca-BMS Mega-Merger Due to Antitrust Concerns
HeraldScotland
20d ago
AstraZeneca in talks over £300bn mega-merger with US rival – reports | The Herald
Financial Times
20d ago
AstraZeneca investors raise concerns over mega-merger talks
linkedin
19d ago
AstraZeneca explores merger with Bristol Myers Squibb | LinkedIn
en.ilsole24ore.com
20d ago
AstraZeneca shares fall in London; according to the FT, a mega-merger with Bristol Myers Squibb is in the offing - Il Sole 24 ORE
Pharmaceutical Technology
20d ago
AstraZeneca shares slump after $400bn BMS merger rumours - Pharmaceutical Technology
Instagram
20d ago
AstraZeneca shares dropped on Monday after reports that the company had discussed a potential mega-merger with Bristol Myers Squibb, a deal that analysts said would be a surprising strategic move for ...
Pharmaceutical Executive
20d ago
AstraZeneca and Bristol Myers Squibb Held Merger Talks: Report | PharmExec
streamlinefeed.co.ke
20d ago
AstraZeneca Plunges as KES 52 Trillion Mega-Merger Talks with Bristol Myers Squibb Emerge | Streamline
pm360online.com
20d ago
AstraZeneca investors baulk at $400 billion Bristol Myers talks – PM360
Global Banking And Finance Review
20d ago
AstraZeneca Shares Fall 7% After Bristol Myers Merger Talks Report
Invezz
20d ago
Bristol-Myers stock: why AstraZeneca merger is unlikely to happen